NASDAQ:PCVX | Profit Breakdown | Vaxcyte, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$302.78M-$284.3M
2026-03-31-$345.85M-$320.62M
2025-12-31-$274.28M-$246.51M
2025-09-30-$242.38M-$212.83M
2025-06-30-$226.22M-$166.57M
2025-03-31-$180.79M-$140.72M
2024-12-31-$162.17M-$137.08M
2024-09-30-$139.92M-$103.12M
2024-06-30-$152.98M-$128.7M
2024-03-31-$114.47M-$95.02M
2023-12-31-$196.68M-$180.8M
2023-09-30-$113.03M-$92.66M
2023-06-30-$87.15M-$68.34M
2023-03-31-$71.19M-$60.46M
2022-12-31-$86.57M-$78.05M
2022-09-30-$58.58M-$57.92M
2022-06-30-$47.89M-$48.53M
2022-03-31-$39.22M-$38.99M
2021-12-31-$29.85M-$28.56M
2021-09-30-$26.95M-$26.62M
2021-06-30-$23.73M-$23.68M
2021-03-31-$23.14M-$21.22M
2020-12-31-$19.45M-$20.74M
2020-09-30-$21.31M-$21.02M
2020-06-30-$21.22M-$20.32M
2020-03-31-$27.6M-$27.14M
2019-12-31-$15.84M-$14.62M
2019-09-30-$12.14M-$11.32M
2019-06-30-$12.23M-$10.67M
2019-03-31-$13.67M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$923.68M-$766.63M
2024-12-31-$569.55M-$463.93M
2023-12-31-$468.04M-$402.27M
2022-12-31-$232.26M-$223.49M
2021-12-31-$103.67M-$100.08M
2020-12-31-$89.58M-$89.22M
2019-12-31-$54.15M-$50.27M
2018-12-31-$35.53M-$29.49M